Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

A*STAR and NUS Launch Joint Centre

Published: Thursday, October 10, 2013
Last Updated: Thursday, October 10, 2013
Bookmark and Share
The S$148 million centre will study the role of nutrition and early development in health and disease in Asia.

The National University of Singapore (NUS) and A*STAR will be jointly establishing the S$148 million Singapore Centre for Nutritional Sciences, Metabolic Diseases, and Human Development (SiNMeD). This collaboration between the NUS's Yong Loo Lin School of Medicine (YLLSoM) and A*STAR's Singapore Institute for Clinical Sciences (SICS) is set to become the leading centre in Asia for research in the nexus between nutritional sciences, metabolic diseases and human development.

SiNMeD will focus on fundamental, clinical and translational research to understand the role of nutrition and early development in the onset and progression of obesity and metabolic diseases like diabetes. Research on the nutritional needs of Asians is lacking and this will be a special focus of the programme. The key research programmes are in early development which will focus on mother and infant nutrition, growth and developmental epigenetics; nutritional sciences which aim to develop strategies for optimal nutrition; and metabolic diseases which will study obesity and insulin resistance in Asians. This is significant to Singapore as it addresses the rising incidence of obesity and diabetes in an Asian context, with up to 25% of the Singapore adult population projected to have type 2 diabetes by 2025.

These research programmes build on existing collaborations, which have already attracted significant investments from major food and nutrition companies who recognise the value of research to develop innovative products for their consumers. SiNMeD's research programmes will expand on the success of the unique and internationally recognised GUSTO birth cohort study, as well as the EpiGen consortium - an international alliance of the world's leading epigenetics researchers.

SiNMeD will be the focal point in Singapore for clinicians, scientists and companies to explore research collaborations in nutritional sciences, epigenetics, developmental determinants of chronic diseases and metabolic disease. "This is the time to bring these multidisciplinary and complementary programmes with NUS together under one umbrella. The SiNMeD investigators have demonstrated the ability to work together to garner both peer-reviewed academic support and to partner with industry in collaborative research programmes" says Professor Judith Swain, MD, Executive Director of A*STAR's SICS and Lien Ying Chow Professor of Medicine at NUS' YLLSoM.

There is growing interest in how the incidence, progression, and treatment of diseases may be different in Asia, and how Asian preferences and culture influence human development and the maintenance of health throughout life, especially the burning topic of "healthy ageing". As Singapore has excellent healthcare and research capabilities, and is well positioned to study health and disease in Asian populations, it provides a strong value proposition for companies seeking to develop products for Asia's diverse populations. Leading nutrition companies like Danone and Abbott have already established research units in Biopolis in Singapore, while others like Nestle have a strong history of research collaborations with A*STAR.

Dr Benjamin Seet, Executive Director of A*STAR's Biomedical Research Council said, "SiNMeD's research will help us to understand how the food we eat can lead to epigenetic changes in our DNA, which will in turn, either protect or predispose us to diseases like obesity and diabetes. This opens up new approaches to prevent and treat these diseases." He added, "This area of research represents a strategic research thrust for A*STAR and Singapore. If we do this well, it will provide a unique and very competitive platform that will conduct cutting-edge research, as well as serve to strengthen our partnerships with some of the world's largest nutrition companies."

SiNMeD will also serve as a focal point for talent development of all levels from undergraduate and graduate students, to post-doctoral and clinical fellows, both locally as well as internationally. SiNMeD will be a magnet for attracting the best young trainees and faculty who are interested in human development, metabolic diseases and nutritional science.

"Our knowledge of how optimal nutrition and lifestyle can delay or prevent disease onset in Asians is sadly lacking. SiNMeD will pool the expertise of NUS and A*STAR to greatly improve our knowledge of this area, to the betterment of society," said Prof Barry Halliwell, NUS' Deputy President (Research and Technology) and Tan Chin Tuan Centennial Professor.

SiNMeD will be headed by its Founding Director Associate Professor Chong Yap Seng of NUS, who also serves as the Deputy Executive Director of SICS. SiNMeD will be made up of a strong team of clinical and basic scientists from A*STAR and NUS, leveraging on the key capabilities of both institutions.

Associate Professor Chong Yap Seng explained how international and local researchers have been brought together to work on this important area in Singapore. He said, "The S$25 million Metabolic Translational and Clinical Research (TCR) Flagship Programme grant awarded by the National Research Foundation in 2008 brought clinical investigators from NUHS, KKH, SGH and TTSH together with researchers from SICS and other A*STAR research institutes. With our partners from the UK and New Zealand in EpiGen, we had the critical mass of talent and resources to compete on the world stage. We have never looked back since."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Advancing the Understanding and Research of Botulinum Neurotoxin Biology
Ipsen and the Institute of Molecular and Cell Biology (IMCB) announce the signature of a research partnership to study the intracellular trafficking of botulinum neurotoxins (BoNTs) within neurons.
Monday, May 16, 2016
A*STAR Findings on Breast Cancer Hold Potential for New Treatments
Computational techniques to increase understanding of diseases and improve patient treatments.
Friday, October 30, 2015
Rapid Test Kit Detects Dengue Antibodies from Saliva
IBN’s MedTech innovation simplifies diagnosis of infectious diseases.
Friday, January 30, 2015
A*STAR Scientists Discover Gene Critical for Proper Brain Development
This gene accounts for the size of the human brain and potentially our superior cognitive abilities.
Friday, December 26, 2014
A Gold Catalyst for Clear Water
Mixed nanoparticle systems may help purify water and generate hydrogen.
Wednesday, December 24, 2014
Anti-Diabetic Drug Springs New Hope for Tuberculosis Patients
Drug for treating diabetes can double up as adjunct treatment for tuberculosis.
Wednesday, December 17, 2014
Gene Associated with an Aggressive Breast Cancer Identified
Over-expressed gene in triple negative breast cancer offers new diagnostics for risk assessment.
Wednesday, December 03, 2014
Diagnostics Development Hub To Complement Biomed Research Launched
Hub will leverage strategic public-public and public-private partnerships to accelerate market readiness of locally developed diagnostic products.
Friday, November 28, 2014
Protecting the Body from Itself
Scientists advance understanding of autoimmunity with discovery of link between major immune cell types.
Friday, September 26, 2014
Colorful Nanoprobes Make A Simple Test
Gold nanoparticles linked to single-stranded DNA create a simple but versatile genetic testing kit.
Thursday, September 25, 2014
Lab on a Breathing Chip
Human nasal epithelial cells, cultured on a microchip, react to air pollutants just like they would in the upper airway.
Saturday, September 13, 2014
Understanding and Improving the Body's Fight Against Pathogens
A*STAR scientists find new targets for modulating antibody response.
Tuesday, September 02, 2014
Novel Gene Predicts Both Breast Cancer Relapse and Response to Chemotherapy
A predictive marker discovered by scientists at A*STAR and NUS could help doctors classify breast cancer patients for more effective treatment.
Thursday, August 21, 2014
High Capacity Antibody Purification
Researchers from the A*Star Bioprocessing Technology Institute have used magnetic nanoparticles to break the capacity barrier for antibody purification.
Sunday, August 17, 2014
New Tool to Study Critical Protein Interaction in Cancer Research
A*STAR scientists used fluorescent molecular rotors to study protein-protein interactions involving p53 and MDM2 in cells.
Thursday, July 03, 2014
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!